Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #1,351 to #1,400.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Rodriguez-Garcia A, et al. FEBS J. (2017) cited as Ref 348 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  2. (hist) ‎Wang XH, et al. Tumour Biol. (2016) cited as Ref 347 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  3. (hist) ‎Xia W, et al. Oncotarget (2017) cited as Ref 346 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  4. (hist) ‎Kaowinn S, et al. Biochem. Biophys. Res. Commun. (2019) cited as Ref 345 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  5. (hist) ‎Romero D, et al. Carcinogenesis (2016) cited as Ref 344 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  6. (hist) ‎Massague J, et al. Genes Dev. (2005) cited as Ref 343 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  7. (hist) ‎Moustakas A, et al. J. Cell Sci. (2001) cited as Ref 342 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  8. (hist) ‎Brown JA, et al. Cell Stem Cell (2017) cited as Ref 341 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  9. (hist) ‎Weiss A, et al. Wiley Interdiscip. Rev. Dev. Biol. (2013) cited as Ref 340 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  10. (hist) ‎Frolik CA, et al. Proc. Natl Acad. Sci. USA (1983) cited as Ref 339 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  11. (hist) ‎Yang Y, et al. Mol. Cancer (2017) cited as Ref 338 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  12. (hist) ‎Che S, et al. Tumour Biol. (2015) cited as Ref 337 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  13. (hist) ‎Jia H, et al. Oncogene (2017) cited as Ref 336 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  14. (hist) ‎Almiron Bonnin DA, et al. Oncogene (2018) cited as Ref 335 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  15. (hist) ‎Zhou B, et al. J. Clin. Invest. (2014) cited as Ref 334 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  16. (hist) ‎Zhang X, et al. Cell Death Dis. (2018) cited as Ref 333 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  17. (hist) ‎Marotta LL, et al. J. Clin. Invest. (2011) cited as Ref 332 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  18. (hist) ‎Ruan Z, et al. Cancer Manag. Res. (2019) cited as Ref 331 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  19. (hist) ‎Kim SY, et al. Cell. Signal. (2013) cited as Ref 330 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  20. (hist) ‎Yang L, et al. Int. J. cancer (2019) cited as Ref 329 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  21. (hist) ‎Zhou J, et al. Proc. Natl Acad. Sci. USA (2007) cited as Ref 328 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  22. (hist) ‎Chambers I, et al. Cloning Stem Cells (2004) cited as Ref 327 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  23. (hist) ‎Rajala HL, et al. Blood (2013) cited as Ref 326 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  24. (hist) ‎Yu H, et al. Nat. Rev. Cancer (2009) cited as Ref 325 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  25. (hist) ‎Karunanithi S, et al. Stem Cell Rep. (2017) cited as Ref 324 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  26. (hist) ‎Kanno H, et al. Int. J. Oncol. (2013) cited as Ref 323 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  27. (hist) ‎Jiang C, et al. J. Exp. Clin. Cancer Res. (2017) cited as Ref 322 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  28. (hist) ‎Lam LT, et al. Blood (2008) cited as Ref 321 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  29. (hist) ‎Van der Zee M, et al. Cancer Res. (2015) cited as Ref 320 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  30. (hist) ‎Song JI, et al. Oncogene (2000) cited as Ref 319 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  31. (hist) ‎James C, et al. Nature (2005) cited as Ref 318 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  32. (hist) ‎Roder S, et al. Exp. Hematol. (2001) cited as Ref 317 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  33. (hist) ‎Levine RL, et al. Cancer Cell (2005) cited as Ref 316 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  34. (hist) ‎Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  35. (hist) ‎Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  36. (hist) ‎Constantinescu SN, et al. Trends Biochem. Sci. (2008) cited as Ref 313 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  37. (hist) ‎Leonard WJ, et al. Annu. Rev. Immunol. (1998) cited as Ref 312 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  38. (hist) ‎Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  39. (hist) ‎Stroud RM, et al. Sci. STKE (2004) cited as Ref 310 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  40. (hist) ‎Quintas-Cardama A, et al. Clin. Cancer Res. (2013) cited as Ref 309 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  41. (hist) ‎Yoshimura A, et al. EMBO J. (1995) cited as Ref 308 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  42. (hist) ‎Haan C, et al. Biochem. Pharmacol. (2006) cited as Ref 307 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  43. (hist) ‎Ihle JN, et al. Trends Genet. (1995) cited as Ref 306 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  44. (hist) ‎O'Shea JJ, et al. Cell (2002) cited as Ref 305 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  45. (hist) ‎Levy DE, et al. Nat. Rev. Mol. Cell. Biol. (2002) cited as Ref 304 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  46. (hist) ‎Marquardt JU, et al. J. Hepatol. (2015) cited as Ref 303 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  47. (hist) ‎Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  48. (hist) ‎Han D, et al. Oncotarget (2015) cited as Ref 301 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  49. (hist) ‎Yang X, et al. Tumour Biol. (2016) cited as Ref 300 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]
  50. (hist) ‎Liu S, et al. Oncotarget (2017) cited as Ref 299 in DOI: 10.1038/s41392-020-0110-5 ‎[191 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)